Private Market View

XingMaiTong

Huzhou, China · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Juhua Chuanxin.
  • Status: Privately Held (backing).

Investors

1
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for XingMaiTong
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for XingMaiTong are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About XingMaiTong

Manufacturer of innovative medical devices designed to treat peripheral vascular diseases. The company offers end-to-end capabilities from clinical needs assessment and product evaluation to structural design, GMP manufacturing, and commercialisation, enabling hospitals and interventional cardiology teams to improve access to localised peripheral vascular interventional devices and enhanced patient treatment outcomes.

Sector
Healthcare
HQ
Huzhou, China
Founded
2021
Ownership
Privately Held (backing)
PA Mark — not yet priced

XingMaiTong doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in XingMaiTong shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on XingMaiTong in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.